FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Entering a new diagnostic field with approval of its haematology platform and starting local production in Brazil. Also seen: Global approvals · expansion

  • Received Korean manufacturing approval for its haematology platform. Source

Roles often seen at this stageDevice R&D & support · Regulatory affairs · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Boditech Med

An in-vitro diagnostics company making point-of-care immunoassay analysers and cartridges, now expanding into haematology.

CBChroma

Approved

Haematology platform that counts blood cells and measures haemoglobin in about ten minutes; approved for manufacture in Korea.

Completion reported

Received Korean approval to manufacture the CBChroma haematology platform.

Announced

Signed a local production and supply agreement with a Brazilian diagnostics company.

Official role guide

Boditech Med careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 바디텍메드 혈액학 진단시장 본격 진출 ↗네이트 뉴스 · Published 2026-05-28 · Sources checked 2026-11-15 · Original unavailable
  2. 바디텍메드, 브라질 바이오시스와 현지 생산 계약 체결 ↗뉴스타운 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable